Skip to main content

Month: September 2020

Vertex Announces Second Quarter 2020 Financial Results

KING OF PRUSSIA, Pa., Sept. 09, 2020 (GLOBE NEWSWIRE) — Vertex, Inc. (Nasdaq: VERX) (“Vertex” or the “Company”), a leading provider of tax technology and services, today announced financial results for its second quarter ended June 30, 2020.“We are pleased with our strong second quarter performance, driven by revenue growth of 16.5% and ARR growth of 16.4% versus the prior year period,” said David DeStefano, Chairperson and Chief Executive Officer of Vertex. “We’ve also been able to effectively balance our commitment to growth and innovation with profitability by delivering adjusted net income growth of 47.4% to $18.9 million and Adjusted EBITDA margin of 23.6%, an increase of 380 basis points, compared to the second quarter of 2019.”DeStefano continued, “The rapid changes taking place in today’s global business, technology...

Continue reading

DSP Group Appoints Tali Chen as its Chief Business Officer

SAN JOSE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — DSP Group®, Inc. (NASDAQ: DSPG), a leading global provider of wireless chipset and voice processing solutions for converged communications, announced today the appointment of Ms. Tali Chen as its Chief Business Officer. In her expanded role, Ms. Chen will lead DSP Group’s global sales force, FAE teams and corporate marketing and will continue to report to Ofer Elyakim, DSP Group’s CEO.Ms. Chen brings more than 15 years of executive management experience in the semiconductor industry. In her multifaceted role as Chief Marketing Officer, she transformed DSP Group’s corporate marketing and communications, reinforced key customer relationships, and proactively expanded DSP Group’s virtual reach and community support as work-from-home mandates expanded. At the same time, she re-established...

Continue reading

Orgenesis CEO to Participate in Webinar Panel on “New Approaches to COVID-19” on Thursday, September 10th

GERMANTOWN, Md., Sept. 09, 2020 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), today announced that CEO, Vered Caplan, will participate on a virtual panel, entitled, “New Approaches to COVID-19: Hidden Breakthroughs,” being held on Thursday, September 10, 2020 at 1:00 p.m. ET.  The event brings together executives from leading biopharmaceutical companies to discuss how their companies are helping address the COVID-19 pandemic.“As a member of the global biotech community, we are driven by a feeling of responsibility to make an impact on treating or preventing COVID-19 wherever possible,” said Vered Caplan, CEO of Orgenesis. “Our team is working on multiple COVID-19 projects, including a recently announced...

Continue reading

Kymera Therapeutics Appoints Biopharma Veterans Pamela Esposito and Jeff Albers to its Board of Directors

WATERTOWN, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system, today announced the appointments of Pamela Esposito, PhD, and Jeff Albers, JD, to its Board of Directors. Dr. Esposito is Chief Business Officer of Replimune, and Mr. Albers is President and Chief Executive Officer of Blueprint Medicines. Both join the Kymera Board with nearly two decades of biopharmaceutical leadership experience. “I’d like to extend a warm welcome to Pamela and Jeff to Kymera’s Board of Directors,” said Nello Mainolfi, PhD, Co-Founder, President and Chief Executive Officer of Kymera Therapeutics. “Their exceptional...

Continue reading

BioXcel Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

NEW HAVEN, Conn., Sept. 09, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced that Dr. Vimal Mehta, Founder and Chief Executive Officer of BTI, will present at the H.C. Wainwright 22nd Annual Global Investment Conference.Presentation Details:Event: H.C. Wainwright 22nd Annual Global Investment ConferenceDate: Wednesday, September 16, 2020Time: 9:30 AM ETA live webcast of the presentation and the accompanying presentation materials will be accessible through the Investors section of the Company’s website at www.bioxceltherapeutics.com. Following the conference, the webcast will be archived on the Company’s website for at least 30...

Continue reading

Konsolidator signs first customer in the USA

Company announcement 18-2020Søborg, September 9, 2020Konsolidator signs first customer in the USAKonsolidator has signed its first customer in the USA after a tender process. The consultant in charge for the tender found Konsolidator through Google search, and Konsolidator was selected to the final selection process. Konsolidator was presented online and was finally selected among other candidates.The USA customer is a result of Konsolidator’s “go to market” strategy, which emphasizes the strength and reach of digital marketing efforts.Signing the first customer in the USA takes the number of countries where Konsolidator has customers to 10 including Denmark, Sweden, Norway, Finland, Germany, Switzerland, UK, Singapore, Zambia and USA.“Signing a customer in the USA once again illustrates the international potential of our software and...

Continue reading

Lands’ End Announces Participation in the 18th Annual CL King Best Ideas Conference

DODGEVILLE, Wis., Sept. 09, 2020 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) today announced that the Company will be participating in the 18th Annual CL King Best Ideas Conference, held virtually, on Wednesday, September 16, 2020, at 1:15 PM Eastern Time. Jerome Griffith, Chief Executive Officer and President, and Jim Gooch, Executive Vice President, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat.The audio portion of the fireside chat will be webcast live over the internet and can be accessed at http://investors.landsend.com. An online archive will be available for a period of 90 days following the presentation.About Lands’ End, Inc.Lands’ End, Inc. (NASDAQ:LE) is a leading uni-channel retailer of casual clothing, accessories, footwear and home products. We offer products...

Continue reading

Comstock Mining Extends Mineral Leases; Secures Strategic Purchase Option

VIRGINIA CITY, Nev., Sept. 09, 2020 (GLOBE NEWSWIRE) — Comstock Mining Inc. (the “Company”) (NYSE American: LODE) and Comstock Northern Exploration, LLC (“Comstock”), a wholly-owned subsidiary of the Company, entered into a Mineral Exploration and Mining Lease Agreement (the “Lease”) with the Sutro Tunnel Company (“Sutro”), in order to lease certain patented mining claims, exploration rights and town lots in the Gold Hill and Virginia City Mining District in Storey County, Nevada (collectively, the “Sutro Properties”). The Company previously had exclusive rights to explore and mine these same properties and mineral claims beginning in 2008.The Lease is assignable by Comstock and these properties make up part of the Lucerne mine properties and part of the Mineral Exploration lease with Tonogold Resources Inc. (“Tonogold”).  Tonogold...

Continue reading

Calavo Growers Publishes Second Annual Sustainability Highlights Report

SANTA PAULA, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado-industry leader and provider of value-added fresh food, today announced the publication of its sustainability highlights report for 2019. Summarized within, the Company outlines its approach to sustainability and its commitment to long-term ecological balance, environmental soundness and social equity throughout Calavo. The report also details its accomplishments and new initiatives across the areas of facilities and operations, people and communities, and products and governance.In the report, Calavo’s Chief Executive Officer James E. Gibson reflects on the variety of ways the Company delivers on its environmental, social and governance commitments. “Our sustainability priorities are closely tied in with changing stakeholder...

Continue reading

Digital Pathology Market Paces Ahead, Increasing FDA Approvals for Pathology Devices Paves Way for Growth, says Fortune Business Insights

Pune, Sept. 09, 2020 (GLOBE NEWSWIRE) — The global digital pathology market is likely to expand due to the rising use of advanced diagnostic tools for prompt diagnosis of chronic diseases. According to a report, titled “Digital Pathology: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to grow due to the increasing number of people diagnosed with related diseases. Furthermore, the global digital pathology market is likely to grow in the forthcoming years due to recent technological advancements in pathology devices. Recent advancements have induced increasing operational efficacy, which is a major factor propelling growth in the global digital pathology market.Digital pathology is applicable across diverse domains within the healthcare industry. This, as per Fortune Business Insights, is a chief driver...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.